NDC11 61755002004
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 61755-0020-04 | 61755-0020 |
| 61755-0020-4 | 61755-0020 |
| 61755-020-04 | 61755-020 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Praluent | ALIROCUMAB | Regeneron Pharmaceuticals, Inc. | 7bcfbac2-e8ac-4569-8edc-bcde3b1fd172 | 2026-07-16 | Warnings, Adverse reactions | 61755-020-04 61755-020 61755002004 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.